NTLA
Intellia Therapeutics, Inc. · Healthcare
President and CEO John M Leonard sold $280K of Intellia Therapeutics, Inc.
Sold$279,852
$112.26Price
2,493Shares
What NTLA did after the filing
- The stock from Mon, Mar 7 open, $66.34
- −14.0%
- S&P 500, same days
- +3.4%
Measured over 30 trading days, to the Apr 19 close.
Traded Sat, Jan 1. Filed Fri, Mar 4, 9:07 PM ET, after the close. Returns use the Mar 7 open and the Apr 19 close. Not investment advice.